Clarity Capital Partners LLC Sells 76,758 Shares of DarioHealth Corp. (NASDAQ:DRIO)

Clarity Capital Partners LLC trimmed its holdings in DarioHealth Corp. (NASDAQ:DRIOFree Report) by 73.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 28,250 shares of the company’s stock after selling 76,758 shares during the quarter. Clarity Capital Partners LLC owned approximately 0.09% of DarioHealth worth $32,000 at the end of the most recent quarter.

Separately, DLK Investment Management LLC increased its stake in DarioHealth by 71.6% in the third quarter. DLK Investment Management LLC now owns 100,550 shares of the company’s stock worth $113,000 after purchasing an additional 41,943 shares during the period. 33.39% of the stock is currently owned by institutional investors.

DarioHealth Stock Down 2.9 %

Shares of DRIO opened at $0.92 on Tuesday. The firm has a fifty day moving average price of $0.94 and a 200-day moving average price of $1.17. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.26 and a quick ratio of 1.96. DarioHealth Corp. has a 12-month low of $0.71 and a 12-month high of $2.60.

DarioHealth (NASDAQ:DRIOGet Free Report) last issued its earnings results on Thursday, August 8th. The company reported ($0.08) EPS for the quarter, topping analysts’ consensus estimates of ($0.51) by $0.43. The business had revenue of $6.26 million for the quarter, compared to the consensus estimate of $7.57 million. DarioHealth had a negative net margin of 265.33% and a negative return on equity of 74.64%. On average, equities analysts expect that DarioHealth Corp. will post -1.21 EPS for the current year.

DarioHealth Company Profile

(Free Report)

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

Read More

Institutional Ownership by Quarter for DarioHealth (NASDAQ:DRIO)

Receive News & Ratings for DarioHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth and related companies with MarketBeat.com's FREE daily email newsletter.